e-learning
resources
Munich 2014
Saturday, 06.09.2014
PG08 The management of non-CF bronchiectasis: from childhood to adulthood
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
How to interpret microbiological results
J.S. Elborn (Belfast, United Kingdom)
Source:
International Congress 2014 – PG08 The management of non-CF bronchiectasis: from childhood to adulthood
Session:
PG08 The management of non-CF bronchiectasis: from childhood to adulthood
Session type:
Postgraduate Course
Number:
63
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J.S. Elborn (Belfast, United Kingdom). How to interpret microbiological results. International Congress 2014 – PG08 The management of non-CF bronchiectasis: from childhood to adulthood
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
How do we interpret the results?
Source: Annual Congress 2006 - Blood gas workshop
Year: 2006
Laboratorial analysis and clinical interpretation of Mycobacterial species results
Source: Eur Respir J 2005; 26: Suppl. 49, 426s
Year: 2005
Clinical interpretation of spirometry results
Source: Paris 2018 - Educational material
Year: 2018
When to apply which bronchial challenge test and interpretation of the results
Source: Annual Congress 2013 –New ATS/ERS recommendations for bronchial challenge testing
Year: 2013
How do we interpret the sample data?
Source: International Congress 2014 – PG17 Lung cancer: the issue with the tissue
Year: 2014
Interpretating the results of spirometry and anamnesis into a diagnose and an advice for treatment: validation and reliability
Source: Eur Respir J 2004; 24: Suppl. 48, 87s
Year: 2004
How to interpret spirometry
Source: ISSN=ISSN 1810-6838, ISBN=, page=259
Year: 2008
Modern approaches to statistical analysis and interpretation of results
Source: Annual Congress 2008 - PG10 - Getting it right – planning, realising, analysing and publishing research projects
Year: 2008
Basic interpretation of histopathological findings in the lung
Source: Annual Congress 2012 - PG3 Radiological-pathological correlation of tumoural and non-tumoural pathology: an interdisciplinary approach
Year: 2012
The clinical usefulness of spirometric information
Source: Breathe 2008; 5: 214-220
Year: 2009
Is there a need for ongoing support for the interpretation of spirometry results by general practitioners?
Source: Eur Respir J 2006; 28: Suppl. 50, 740s
Year: 2006
Interpretation of the results in the clinic
Source: International Congress 2015 – PG10 Malignant pleural effusion management
Year: 2015
How to translate findings from experimental models into clinical studies in OSA
Source: Research seminar - Targeting the detrimental effects of sleep disturbances and disorders – towards personalized treatment in respiratory diseases
Year: 2019
How to use monitoring data to make wise clinical decisions
Source: International Congress 2015 – PG3 Cardiorespiratory monitoring in critically ill patients
Year: 2015
Are
in vitro
sensitivity tests for tuberculosis drugs a good guide of clinical outcome?
Source: Annual Congress 2006 - The management of multidrug-resistant tuberculosis (MDRTB) on an individual and national level
Year: 2006
The importance of the bacteriological and histopathological confirmation in children with tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 624s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept